Literature DB >> 21529757

Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis.

Agustín Conde-Agudelo1, Roberto Romero, Juan Pedro Kusanovic, Sonia S Hassan.   

Abstract

OBJECTIVE: To determine whether supplementation with vitamins C and E during pregnancy reduces the risk of preeclampsia and other adverse maternal and perinatal outcomes. STUDY
DESIGN: Systematic review and metaanalysis of randomized controlled trials.
RESULTS: Nine trials involving a total of 19,810 women were included. Overall, there were no significant differences between the vitamin and placebo groups in the risk of preeclampsia (9.6% vs 9.6%; relative risk, 1.00, 95% confidence interval, 0.92-1.09). Similar results were obtained when subgroup analyses were restricted to women at high risk or low/moderate risk for preeclampsia. Women supplemented with vitamins C and E were at increased risk of developing gestational hypertension and premature rupture of membranes, and decreased risk of abruptio placentae. There were no significant differences between the vitamin and placebo groups in the risk of other adverse maternal or fetal/perinatal outcomes.
CONCLUSION: Supplementation with vitamins C and E during pregnancy does not prevent preeclampsia. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21529757      PMCID: PMC3380625          DOI: 10.1016/j.ajog.2011.02.020

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  42 in total

Review 1.  Unexpected results of an important trial of vitamins C and E administration to prevent preeclampsia.

Authors:  Roberto Romero; Thomas J Garite
Journal:  Am J Obstet Gynecol       Date:  2006-05       Impact factor: 8.661

2.  A meta-analysis on the efficacy and safety of combined vitamin C and E supplementation in preeclamptic women.

Authors:  Roja Rahimi; Shekoufeh Nikfar; Ali Rezaie; Mohammad Abdollahi
Journal:  Hypertens Pregnancy       Date:  2009-08       Impact factor: 2.108

3.  Vitamins C and E and the risks of preeclampsia and perinatal complications.

Authors:  Alice R Rumbold; Caroline A Crowther; Ross R Haslam; Gustaaf A Dekker; Jeffrey S Robinson
Journal:  N Engl J Med       Date:  2006-04-27       Impact factor: 91.245

Review 4.  Is vitamin E a safe prophylaxis for preeclampsia?

Authors:  Subhasis Banerjee; Anne E Chambers; Stuart Campbell
Journal:  Am J Obstet Gynecol       Date:  2006-03-30       Impact factor: 8.661

Review 5.  Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review.

Authors:  Nikolaos P Polyzos; Davide Mauri; Maria Tsappi; Spyridon Tzioras; Konstantinos Kamposioras; Ivan Cortinovis; Giovanni Casazza
Journal:  Obstet Gynecol Surv       Date:  2007-03       Impact factor: 2.347

6.  Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial.

Authors:  Dorothy Beazley; Robert Ahokas; Jeffrey Livingston; Mary Griggs; Baha M Sibai
Journal:  Am J Obstet Gynecol       Date:  2005-02       Impact factor: 8.661

7.  Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.

Authors:  L Poston; A L Briley; P T Seed; F J Kelly; A H Shennan
Journal:  Lancet       Date:  2006-04-08       Impact factor: 79.321

8.  The two stage model of preeclampsia: variations on the theme.

Authors:  J M Roberts; C A Hubel
Journal:  Placenta       Date:  2008-12-13       Impact factor: 3.481

9.  Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial.

Authors:  David R McCance; Valerie A Holmes; Michael J A Maresh; Christopher C Patterson; James D Walker; Donald W M Pearson; Ian S Young
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321

10.  Placental stress and pre-eclampsia: a revised view.

Authors:  C W G Redman; I L Sargent
Journal:  Placenta       Date:  2009-01-12       Impact factor: 3.481

View more
  43 in total

1.  Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Zeynep Alpay Savasan; Juan Pedro Kusanovic; Giovanna Ogge; Eleazar Soto; Zhong Dong; Adi Tarca; Bhatti Gaurav; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-09

2.  SOD1 suppresses maternal hyperglycemia-increased iNOS expression and consequent nitrosative stress in diabetic embryopathy.

Authors:  Hongbo Weng; Xuezheng Li; E Albert Reece; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2012-02-22       Impact factor: 8.661

Review 3.  The role of FOXO1 in the decidual transformation of the endometrium and early pregnancy.

Authors:  Takeshi Kajihara; Jan J Brosens; Osamu Ishihara
Journal:  Med Mol Morphol       Date:  2013-02-05       Impact factor: 2.309

4.  Pomegranate juice and punicalagin attenuate oxidative stress and apoptosis in human placenta and in human placental trophoblasts.

Authors:  Baosheng Chen; Methodius G Tuuli; Mark S Longtine; Joong Sik Shin; Russell Lawrence; Terrie Inder; D Michael Nelson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-28       Impact factor: 4.310

5.  Maternal Interleukin Genotypes Are Associated With NICU Outcomes Among Low-Birth-Weight Infants.

Authors:  Kelley L Baumgartel; Maureen W Groer; Susan M Cohen; Dianxu Ren; Diane L Spatz; Yvette P Conley
Journal:  Biol Res Nurs       Date:  2016-09-20       Impact factor: 2.522

6.  Obesity during pregnancy alters maternal oxidant balance and micronutrient status.

Authors:  S Sen; C Iyer; S N Meydani
Journal:  J Perinatol       Date:  2013-12-19       Impact factor: 2.521

7.  Superoxide dismutase 1 overexpression in mice abolishes maternal diabetes-induced endoplasmic reticulum stress in diabetic embryopathy.

Authors:  Fang Wang; E Albert Reece; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2013-06-20       Impact factor: 8.661

Review 8.  p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes.

Authors:  Ramkumar Menon; John Papaconstantinou
Journal:  Expert Opin Ther Targets       Date:  2016-08-04       Impact factor: 6.902

Review 9.  Precision test for precision medicine: opportunities, challenges and perspectives regarding pre-eclampsia as an intervention window for future cardiovascular disease.

Authors:  Xin Zhou; Jian-Min Niu; Wen-Jie Ji; Zhuoli Zhang; Peizhong P Wang; Xue-Feng B Ling; Yu-Ming Li
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 10.  Pre-eclampsia part 2: prediction, prevention and management.

Authors:  Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Steven J Korzeniewski; Lami Yeo; Roberto Romero
Journal:  Nat Rev Nephrol       Date:  2014-07-08       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.